Gene and cell therapy (GCT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. Viral vectors are useful vehicles in delivering gene of interest (GOI) in gene and cell therapies, and therefore, the safety and stable manufacturing of viral vectors are drawing attention. GenScript ProBio is dedicated to developing comprehensive and stable platform to support with the development and manufacturing of various kinds of viral vectors.
Working within GMP regulations, GenScript ProBio offers cell and viral banking manufacturing services to customers.
One-stop solution covering process development, analytical development, GMP manufacturing and stability test to support regulatory filings.
GMP lentiviral vector is manufactured compliant to GMP regulations, suitable for early phase clinical trials.
Our customer service representatives are available 24 hours a day, Monday through Friday, to assist you.